Market Closed -
OTC Markets
15:18:05 2024-04-30 EDT
5-day change
1st Jan Change
1.2
USD
+471.16%
-.--%
+471.16%
Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Bioethics, Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was USD 0.021679 million compared to USD 0.028175 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.
Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
04-11
CI
Bioethics, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-14
CI
Bioethics, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-09
CI
Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-19
CI
Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-04-17
CI
Bioethics, Ltd. Auditor Raises 'Going Concern' Doubt
23-04-16
CI
Bioethics, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-21
CI
Bioethics, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
22-08-15
CI
Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-23
CI
Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
22-04-15
CI
Bioethics, Ltd. Auditor Raises 'Going Concern' Doubt
22-04-14
CI
Bioethics, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
21-11-19
CI
Bioethics, Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
21-08-23
CI
Bioethics, Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
20-11-19
CI
XCR Diagnostics, Inc. entered into a non-binding term sheet to acquire Bioethics, Ltd. in a reverse merger transaction for approximately $110 million.
20-07-30
CI
Bioethics, Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
20-07-28
CI
Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
20-05-14
CI
Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
20-04-09
CI
Bioethics, Ltd. Announces Director Resignations
20-03-05
CI
Bioethics, Ltd. Announces Executive Changes
20-01-24
CI
Bioethics, Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
19-11-14
CI
Bioethics, Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
19-08-14
CI
Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019
19-05-15
CI
Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018
19-03-19
CI
Tranche Update on Bioethics, Ltd.'s Equity Buyback Plan announced on March 8, 2018.
18-05-16
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Bioethics, Ltd. is a shell company. The Company is formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The Company has not commenced any operations nor generated any revenue.
More about the company
1st Jan change
Capi.
+471.16% 1.36M +190.94% 6.96B +2.14% 982M +41.91% 872M +26.98% 830M +1.72% 664M +5.92% 642M -.--% 600M +3.61% 503M -.--% 500M
Shell Companies
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
BIOETHICS, LTD. 
